1. Market Research
  2. > Healthcare Market Trends
The Global Blood Industry

The Global Blood Industry

  • May 2017
  • 293 pages
  • ID: 1498888
  • Format: PDF
  • By BCC Research


Table of Contents

• The global sales of blood products reached $31.8 billion in 2015 and $33.5 billion in 2016. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 4.9% from 2016 to 2021, reaching nearly $42.6 billion in 2021.
• Blood therapeutics as a segment reached $27.2 billion in 2016 and should reach $35.0 billion by 2021, with a CAGR of 5.2%.
• Blood-screening and blood-typing products a s a segment reached $3.8 billion in 2016 and should reach nearly $4.9 billion by 2021, with a CAGR of 5.2%.


Study Goals and Objectives
The goals of this study on the blood industry are to describe and analyze the current markets for blood products, blood tests and blood-processing equipment, as well as present important new developments affecting every aspect of this industry. In addition, the report provides an analysis of market-value forecast through 2021 in constant dollars, as well as profiles of companies in the industry. The study covers the major aspects of blood and plasma collection/transfusion, including autologous donations, apheresis, fractionation, blood salvage and stem cells. The major plasma products such as coagulation factors, human serum albumin and immunoglobulins are analyzed as well. The scope and character of the blood-testing segment is changing constantly so the impact of new products, technologies and equipment is analyzed. The study also covers international developments in blood banking and related areas, as well as research and patents that will affect the future of the blood industry.

Reasons for Doing This Study
A safe and adequate blood supply is essential to the practice of modern medicine. The U.S. blood industry is safe and blood supplies are usually adequate. Current efforts in the industry are focused on increasing the blood supply in other world markets and improving education efforts for a safe and sufficient blood supply globally. New advances, particularly in the area of automation, have enhanced both safety and blood availability, and it is the purpose of this study to detail these advances and their impact on the blood industry. There have been advances in technology that have allowed more red blood cells to be obtained from fewer donors. Technological advances have also allowed for greater economies and increased safety in the blood supply.

Contribution of the Study and Intended Audience
With its broad scope and in-depth analyses, this study will prove to be a valuable resource to anyone involved with or interested in the blood industry. This study will provide information on these areas:

- The structure and current market size of the blood industry with forecasts through 2021.
- Blood-usage patterns and trends.
- Government and regulatory controls.
- The impact of disease on the blood industry.
- Major players and their relative market share and market potential.
- Current product lines and examination of newly emerging products and technologies.
- The state of the international markets for various blood and blood-related products.
- Newly issued patents relating to blood- and disease-screening technologies.

Since the study provides business and technical information of a timely nature, it will prove valuable to a variety of readers, including industry executives, managers and planners, researchers, industry analysts and investors. The projections, forecasts and trend analyses found in this report provide readers with
the necessary data and information for careful decision-making.

Scope and Format
This study encompasses the wide range of products and services that comprise the global blood-industry marketplace. The U.S. market, the largest in the world, provides the primary market breakdown with supplemental information given for other regions. The focus of the report is two-fold: first, blood for donation and the components and derived products from this blood and plasma, and second, products used to provide and support collection, processing and transfusion. Excluded from consideration are the clinical blood tests for diseases and conditions not involved in managing blood and plasma products.

Methodology and Information Sources
Data for this study were collected using both primary and secondary data research techniques. Literature searches of various sources including scientific, medical and business publications and databases were conducted. On-line databases and government sources were consulted as well. Extensive interviews were conducted with industry personnel, scientists, professional and trade organizations, government agency personnel, observers, scientists and industry professionals. The collected data were analyzed to determine specific findings and forecasts. Once these forecasts were obtained, they were validated with industry experts. Since some segments of this report are not measured routinely, BCC Research derived estimates from a variety of analogous sources.

Whenever market estimates are derived, they are fully noted. It should be pointed out that, while many factors were considered in constructing different models, the projections are ultimately speculative. As a composite of the opinions and assessments of interviewees, the author, other analysts and secondary
sources, these projections represent something of a consensus. However, all recognize that the relative importance of selected factors could change at any time with new technologies and new products, and thus change the direction of the market projections. All forecasts use constant 2014 U.S. dollars.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on